NS Partners’s Thermo Fisher Scientific TMO Stock Holding History

NS Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.2M	Buy	+22,537	New	+$13.4M	0.65%	40

Other funds holding TMO

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

NS Partners's TMO Position: Q3 2026 in Review

NS Partners opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 22,537 shares worth $15.2M. The stake represents 0.65% of the portfolio and ranks #40 among its holdings.

2,351 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

NS Partners held 22,537 shares of Thermo Fisher Scientific worth $15.2M as of Q3 2026.
Thermo Fisher Scientific was a new NS Partners position in Q3 2026.
Thermo Fisher Scientific made up 0.65% of NS Partners's portfolio in Q3 2026, its #40 holding.
2,351 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on NS Partners's 13F filing for Q3 2026, filed 10 Nov 2026.